Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B (International Review of Neurobiology)

Sharma, Hari Shanker (EDT)/ Wiklund, Lars (EDT)/ Sharma, Aruna (EDT)

Academic Press Inc（2023/10発売）

• 製本 Hardcover:ハードカバー版／ページ数 356 p.
• 言語 ENG
• 商品コード 9780443294686

Full Description

Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors, Part B, Volume 172 in the International Review of Neurobiology series, includes chapters on Spinal cord injury induced exacerbation of Alzheimer's disease pathophysiology in the cord is reduced by topical application of nanowired cerebrolysin and antibodies to tumor necrosis factor alpha, Nanodelivery of histamine H3 receptor inverse agonist BF-2549 with clobenpropit a H3 receptor antagonist and H4 receptor agonist induced neuroprotection in spinal cord injury is potentiated by antioxidant compound H-290/51, and Neuromodulation and quality of life for patient with spasticity after spinal cord injury, and more.

Other sections cover Efficacy of invasive and non-invasive methods for the treatment of Parkinson's disease: nanodelivery and enriched environment, Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with brain injury, Nicotine Neurotoxicity Exacerbation following Engineered Ag and Cu (50-60 nm) nanoparticles intoxication, and Neuroprotection with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron.

Contents

Section I: Spinal cord Injury
1. Spinal cord injury induced exacerbation of Alzheimer's disease pathophysiology in the cord is reduced by topical application of nanowired cerebrolysin and antibodies to tumor necrosis factor alpha
Aruna Sharma
2. Nanodelivery of histamine H3 receptor inverse agonist BF-2549 with clobenpropit a H3 receptor antagonist and H4 receptor agonist induced neuroprotection in spinal cord injury is potentiated by antioxidant compound H-290/51
Anca Dana Buzoianu
3. Neuromodulation and quality of life for patient with spasticity after spinal cord injury
Artur Biktimirov

Section II : Neurodegenerative disease
4. Efficacy of invasive and non-invasive methods for the treatment of Parkinson's disease: nanodelivery and enriched environment
Andreas Vaquero
5. Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with brain injury
Zhenguo G Wang

Section III Drugs of Abuse and Neurotoxicity
6. Nicotine Neurotoxicity Exacerbation following Engineered Ag and Cu (50-60 nm) nanoparticles intoxication. Neuroprotection with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron
Z Ryan Tian

Section IV: Clinical Neurology and Oncology
7. The technology of genomic balancing the hemopoiesis precursor clones by nucleosome monomers of human genomic DNA (hDNAnmr) and perspectives of clinical use
Andrey Bryukhovetskiy
8. An overview of Twist1 in glioma progression and recurrence;
Zhiqiang Zhang
9. A review of traditional Chinese medicine Curcumae Rhizoma for treatment of glioma.
Cong Li
10. A case of a large lumbar schwannoma from a filum terminal and literature review.
Chao He